Global Morphine Sulfate (CAS 64-61-3) Market is expected to rise at a significant CAGR in the forthcoming years.The dosage for Morphine sulfate (CAS 64-31-3) is dependent on the patient’s medical conditions and response to the treatment. The does should not be increased abruptly or the intake should not be exceeded than the prescribed period. Morphine sulfate tablets are controlled-release tables with ingredients like cetostearyl alcohol, hydroxyethyl cellulose, hypromellose, polyethylene glycol, talc, titanium dioxide and magnesium stearate.
Commercial market driving factors responsible for the growth of morphine sulfate market includes demand for painkiller antibiotics and other health conditions. However, the concerned side-effects and health hazards are likely to impede the market growth. Also, ban in some countries on using morphine contributes as a restraining factor.
Based on segmentation by product, the morphine sulfate (CAS 64-31-3) includes powder and pills. Pills dominate the segment owing to growth in prevalence of painkiller and antibiotics. Based on segmentation by end-user, the morphine sulfate (CAS 64-31-3) includes injection and capsule. Capsule dominates the market segment owing to rise in demand for solid oral dosage.
Geographically, morphine sulfate (CAS 64-31-3) market spans North America, Latin America, Europe, Asia-Pacifica, Middle-East and Africa. APAC market dominate the global market owing to presence of enormous pool of customers and rise in medical infrastructure. China, India, Japan, South Korea and Taiwan are leading in the manufacture of the prescribed tablet. North America and Europe market are also expected to grow at a steady CAGR in the forthcoming years owing to ban on morphine in some countries due to its bizarre nature and mode of intake. MEA regions are also expected to rise at a steady CAGR owing to low demand and developing medical infrastructure.
The key players in the morphine sulfate (CAS 64-31-3) market include Mallinckrodt Pharmaceuticals, Purdue Pharma, Cepia-Sanofi, Macfarlan Smith, SUN PHARMA, Qinghai Pharmaceutical, Taj Pharmaceutical and Northeast Pharm.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Morphine Sulfate in these regions, from 2013 to 2025 (forecast), covering
• North America
• Southeast Asia
Global Morphine Sulfate market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
• Mallinckrodt Pharmaceuticals
• Purdue Pharma
• Macfarlan Smith
• SUN PHARMA
• Qinghai Pharmaceutical
• Taj Pharmaceuticals
• Northeast Pharm
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
• Oral Tablets
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
Research Support Specialist, USA